Comparison of Bizact With Electroscissor for Tonsillectomy
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03854279 |
|
Recruitment Status : Unknown
Verified February 2019 by Johan C Ræder, Oslo University Hospital.
Recruitment status was: Recruiting
First Posted : February 26, 2019
Last Update Posted : February 26, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Tonsillar Hypertrophy, Tonsillitis | Device: tonsillar dissection | Phase 4 |
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 60 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Double (Participant, Outcomes Assessor) |
| Primary Purpose: | Treatment |
| Official Title: | Bizact Versus Electroscissor for Adult Tonsillectomy |
| Actual Study Start Date : | February 20, 2019 |
| Estimated Primary Completion Date : | October 31, 2019 |
| Estimated Study Completion Date : | December 31, 2020 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Bizact
Tonsillectomy will be done With the Bizact device
|
Device: tonsillar dissection
The tonsils will be removed by bizact device |
|
Active Comparator: Electro-scissor
Tonsillectomy will be done With electro-scissors
|
Device: tonsillar dissection
The tonsils will be removed by bizact device |
- Postoperative pain: Number of days With need of analgesics [ Time Frame: 2 weeks ]Number of days With need of analgesics
- Postoperative pain: Dose need of pain killers during first 24 hr postoperatively [ Time Frame: 24 hrs ]Dose need of pain killers during first 24 hr postoperatively
- Postoperative bleeding [ Time Frame: 2 weeks ]Incidence of bleeding after discharge
- Per-operative bleeding [ Time Frame: per-operative ]Amount of bleeding during surgery
- Duration of surgery [ Time Frame: 0 - 1 hr ]time from start of surgery to end
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 16 Years to 40 Years (Child, Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- planned elective tonsillectomy
- informed consent
Exclusion Criteria:
- regular use of analgesics pre-operatively
- known tendency of bleeding
- not able to communicate in Norwegian
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03854279
| Contact: Johan Raeder, PhD | 004722119690 | johan.rader@medisin.uio.no |
| Norway | |
| Dept of Anesthesiology, Oslo University Hospital, Ullevaal | Recruiting |
| Oslo, Norway, 0407 | |
| Contact: Johan Rader, PhD 004792249669 johan.rader@medisin.uio.no | |
| Responsible Party: | Johan C Ræder, Professor, Oslo University Hospital |
| ClinicalTrials.gov Identifier: | NCT03854279 |
| Other Study ID Numbers: |
Bizact study |
| First Posted: | February 26, 2019 Key Record Dates |
| Last Update Posted: | February 26, 2019 |
| Last Verified: | February 2019 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Tonsillitis Hypertrophy Pathological Conditions, Anatomical Pharyngitis Respiratory Tract Infections |
Infections Pharyngeal Diseases Stomatognathic Diseases Respiratory Tract Diseases Otorhinolaryngologic Diseases |

